Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025
Angela Rose, Heather Whitaker(Public Health Agency of Canada), Hanne‐Dorthe Emborg(Statens Serum Institut), Héloïse Lucaccioni, Nick Andrews(Boston Children's Hospital), Diogo Marques(Public Health Scotland), Ross McQueenie(University of Glasgow), Karina Lauenborg Møller, Magda Bucholc(University of Ulster), Ramona Trebbien(Ministry of External Affairs), Esther Kissling, Jamie Lopez Bernal(Public Health Agency), Freja Kirsebom(UK Health Security Agency), Safraj Shahul Hameed(Sultan Qaboos University), Francisco Pozo(Instituto de Salud Carlos III), Mark G. O’Doherty(Public Health Agency), Siobhán Murphy(Public Health Agency), Kimberly Marsh(Joint United Nations Programme on HIV/AIDS), Simon Cottrell(Public Health Wales), Amanda Bolt Botnen(Statens Serum Institut), Mark Hamilton(Public Health Scotland)
Cited by 24
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|714
Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery
|British Journal of Anaesthesia|2019|659
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
|Antimicrobial Agents and Chemotherapy|2001|653